Around 60% of oral squamous cell carcinomas (SCCs) have been shown to
harbour p53 mutations, and other studies have demonstrated mutant p53
genes in normal and dysplastic squamous epithelium adjacent to these S
CCs. In line with these earlier studies we show here that DOK, a kerat
inocyte cell line derived from a dysplasia, displays elevated levels o
f p53 protein and harbours a 12 bp in-frame deletion of the p53 gene s
panning codons 188-191. In contrast, the coding region of the p53 gene
was normal in a series of six benign recurrent laryngeal papillomas a
nd a series of four premalignant oral erythroplakia biopsies and their
cell cultures. All but one of these lesions were free of malignancy a
t the time of biopsy, in contrast to the premalignant lesions studied
by previous investigators, but keratinocytes cultured from these lesio
ns all displayed a partially transformed phenotype that was less prono
unced than that of DOK. Since three out of four of the erythroplakia p
atients developed SCC within 1 year of biopsy, these lesions were by d
efinition premalignant. The availability of strains of partially trans
formed keratinocytes from premalignant erythroplakia which possess nor
mal p53 genes should enable us to test the role of mutant p53 in the p
rogression of erythroplakia to SCC. The premalignant tissues and cultu
res were also tested for the presence of human papillomavirus (HPV), w
hich is known to inactivate p53 function in some cases. Only the benig
n papillomas were shown to contain high levels of either HPV 6 or HPV
11 E6 DNA, but not both, and none of the samples contained detectable
levels of HPV 16, HPV 18 or HPV 33 E6 DNA or L1 DNA of several other H
PV types. There was therefore no evidence to suggest that p53 was bein
g inactivated by a highly oncogenic HPV in these samples.